Company intelligence / Profile preview

E-Fund

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

E-Fund is an active early-stage angel and VC investor backing startups in healthcare, biotech, medical devices, and digital health in North America and China. Notable investments include 3D tissue engineering, regenerative medicine, bone-targeted therapeutics, precision supplements, surgical robotics, and digital health communication

Therapeutic areas: EndocrinologyNeurologyRare DiseasesOtherOncology
Modalities: 3D BioprintingSmall moleculeMedical deviceDigital health platformGenetic diagnosticsPersonalized nutrition
Industry: Investors

Partnerships

Frequently co-invests with early-stage VCs and angel investors

Beyond the preview

Go deeper on E-Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-Fund.

Explore the full profile